Media Summary: This presentation provided information about the Small Business and Industry Assistance (SBIA) and its mission. Topics ... To discuss the plausible mechanism guidance and its applicability to both This presentation explored medical device coverage initiatives and the role of the Payor Communication Task Force in connecting ...
Fda Nih 2024 D1s08 Cber - Detailed Analysis & Overview
This presentation provided information about the Small Business and Industry Assistance (SBIA) and its mission. Topics ... To discuss the plausible mechanism guidance and its applicability to both This presentation explored medical device coverage initiatives and the role of the Payor Communication Task Force in connecting ... This presentation provided comprehensive guidance on CDER's nonclinical resources for approaching First-in-Human (FIH) ... This presentation provided guidance on nonclinical assessment of Cell and Gene Therapy (CGT) products to support IND ... This presentation highlighted key clinical regulatory issues encountered during early-phase development of cellular and gene ...
This presentation outlined CDER's clinical considerations for First-in-Human trials and presented general good practices for FIH ... This inaugural webinar was a collaborative effort between Efficient Communication Reduces Regulatory Uncertainty — Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research ( This presentation provided an overview of CDRH's Medical Device Development Tools (MDDT) Program and explained what ... This presentation explored regulatory resources and avenues for obtaining early guidance from
This presentation explained the role and function of the Division of Industry and Consumer Education (DICE) within the
